Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A 13 weeks randomized, double-blind and placebo parallel-controlled trial will be conducted
to evaluate the clinical efficacy and safety of Zhizhu Kuanzhong Capsule in the treatment of
functional dyspepsia-postprandial distress syndrome.
Phase:
N/A
Details
Lead Sponsor:
Hong Kong Baptist University
Collaborator:
Xiyuan Hospital of China Academy of Chinese Medical Sciences